EquityZen Growth Technology Fund LLC - Series 1186
Raised
$1M
Investors
51
Min Invest
$10,003
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1186 is a Delaware pooled investment fund offering pre-IPO equity exposure, filed by EquityZen Advisors LLC. This amended filing reports $1.2M raised from 51 investors with a $10K minimum investment under Rule 506(b) and Section 3(c)(1) exemptions. The entity is part of the EquityZen platform, which operates nearly 1,900 related fund series for secondary pre-IPO share transactions.
This pre-IPO fund follows the standard EquityZen platform model: a single-asset or narrow-mandate SPV structured under 506(b) private placement and 3(c)(1) investment company exemptions. The $10K minimum investment is consistent with retail-accessible pre-IPO vehicles, positioned well below the typical $100K–$250K thresholds seen in traditional venture funds.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
